Celldex Therapeutics Announces 6.5M Share Offering
December 03, 2013 at 16:05 PM EST
Celldex Therapeutics, Inc. (Nasdaq: CLDX ) today announced that it is offering 6.5 million shares of its common stock in a proposed underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or
